Copyright Reports & Markets. All rights reserved.

Global Norovirus Diagnostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Norovirus Diagnostics by Type
    • 1.3.1 Overview: Global Norovirus Diagnostics Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Norovirus Diagnostics Consumption Value Market Share by Type in 2025
    • 1.3.3 Rapid Test Kits
    • 1.3.4 PCR Kits
    • 1.3.5 ELISA Based Kits
  • 1.4 Global Norovirus Diagnostics Market by Application
    • 1.4.1 Overview: Global Norovirus Diagnostics Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Diagnostics Labs
    • 1.4.4 Clinics
  • 1.5 Global Norovirus Diagnostics Market Size & Forecast
  • 1.6 Global Norovirus Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Norovirus Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Norovirus Diagnostics Market Size by Region, (2021-2032)
    • 1.6.3 North America Norovirus Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Norovirus Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Norovirus Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.6 South America Norovirus Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Norovirus Diagnostics Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Norovirus Diagnostics Product and Solutions
    • 2.1.4 Abbott Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Recent Developments and Future Plans
  • 2.2 R-Biopharm
    • 2.2.1 R-Biopharm Details
    • 2.2.2 R-Biopharm Major Business
    • 2.2.3 R-Biopharm Norovirus Diagnostics Product and Solutions
    • 2.2.4 R-Biopharm Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 R-Biopharm Recent Developments and Future Plans
  • 2.3 ELITechGroup
    • 2.3.1 ELITechGroup Details
    • 2.3.2 ELITechGroup Major Business
    • 2.3.3 ELITechGroup Norovirus Diagnostics Product and Solutions
    • 2.3.4 ELITechGroup Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 ELITechGroup Recent Developments and Future Plans
  • 2.4 Danaher Corporation (Cepheid)
    • 2.4.1 Danaher Corporation (Cepheid) Details
    • 2.4.2 Danaher Corporation (Cepheid) Major Business
    • 2.4.3 Danaher Corporation (Cepheid) Norovirus Diagnostics Product and Solutions
    • 2.4.4 Danaher Corporation (Cepheid) Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Danaher Corporation (Cepheid) Recent Developments and Future Plans
  • 2.5 Meridian Bioscience
    • 2.5.1 Meridian Bioscience Details
    • 2.5.2 Meridian Bioscience Major Business
    • 2.5.3 Meridian Bioscience Norovirus Diagnostics Product and Solutions
    • 2.5.4 Meridian Bioscience Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Meridian Bioscience Recent Developments and Future Plans
  • 2.6 Eiken Chemical
    • 2.6.1 Eiken Chemical Details
    • 2.6.2 Eiken Chemical Major Business
    • 2.6.3 Eiken Chemical Norovirus Diagnostics Product and Solutions
    • 2.6.4 Eiken Chemical Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Eiken Chemical Recent Developments and Future Plans
  • 2.7 Altona Diagnostics
    • 2.7.1 Altona Diagnostics Details
    • 2.7.2 Altona Diagnostics Major Business
    • 2.7.3 Altona Diagnostics Norovirus Diagnostics Product and Solutions
    • 2.7.4 Altona Diagnostics Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Altona Diagnostics Recent Developments and Future Plans
  • 2.8 CerTest Biotec
    • 2.8.1 CerTest Biotec Details
    • 2.8.2 CerTest Biotec Major Business
    • 2.8.3 CerTest Biotec Norovirus Diagnostics Product and Solutions
    • 2.8.4 CerTest Biotec Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 CerTest Biotec Recent Developments and Future Plans
  • 2.9 Elisabeth Pharmacon
    • 2.9.1 Elisabeth Pharmacon Details
    • 2.9.2 Elisabeth Pharmacon Major Business
    • 2.9.3 Elisabeth Pharmacon Norovirus Diagnostics Product and Solutions
    • 2.9.4 Elisabeth Pharmacon Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Elisabeth Pharmacon Recent Developments and Future Plans
  • 2.10 Qiagen
    • 2.10.1 Qiagen Details
    • 2.10.2 Qiagen Major Business
    • 2.10.3 Qiagen Norovirus Diagnostics Product and Solutions
    • 2.10.4 Qiagen Norovirus Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Qiagen Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Norovirus Diagnostics Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Norovirus Diagnostics by Company Revenue
    • 3.2.2 Top 3 Norovirus Diagnostics Players Market Share in 2025
    • 3.2.3 Top 6 Norovirus Diagnostics Players Market Share in 2025
  • 3.3 Norovirus Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Norovirus Diagnostics Market: Region Footprint
    • 3.3.2 Norovirus Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Norovirus Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Norovirus Diagnostics Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Norovirus Diagnostics Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Norovirus Diagnostics Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Norovirus Diagnostics Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Norovirus Diagnostics Consumption Value by Type (2021-2032)
  • 6.2 North America Norovirus Diagnostics Market Size by Application (2021-2032)
  • 6.3 North America Norovirus Diagnostics Market Size by Country
    • 6.3.1 North America Norovirus Diagnostics Consumption Value by Country (2021-2032)
    • 6.3.2 United States Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Norovirus Diagnostics Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Norovirus Diagnostics Consumption Value by Type (2021-2032)
  • 7.2 Europe Norovirus Diagnostics Consumption Value by Application (2021-2032)
  • 7.3 Europe Norovirus Diagnostics Market Size by Country
    • 7.3.1 Europe Norovirus Diagnostics Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.3 France Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Norovirus Diagnostics Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Norovirus Diagnostics Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Norovirus Diagnostics Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Norovirus Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Norovirus Diagnostics Consumption Value by Region (2021-2032)
    • 8.3.2 China Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.5 India Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Norovirus Diagnostics Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Norovirus Diagnostics Consumption Value by Type (2021-2032)
  • 9.2 South America Norovirus Diagnostics Consumption Value by Application (2021-2032)
  • 9.3 South America Norovirus Diagnostics Market Size by Country
    • 9.3.1 South America Norovirus Diagnostics Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Norovirus Diagnostics Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Norovirus Diagnostics Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Norovirus Diagnostics Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Norovirus Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Norovirus Diagnostics Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Norovirus Diagnostics Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Norovirus Diagnostics Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Norovirus Diagnostics Market Drivers
  • 11.2 Norovirus Diagnostics Market Restraints
  • 11.3 Norovirus Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Norovirus Diagnostics Industry Chain
  • 12.2 Norovirus Diagnostics Upstream Analysis
  • 12.3 Norovirus Diagnostics Midstream Analysis
  • 12.4 Norovirus Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Norovirus Diagnostics market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Norovirus diagnostics refer to the methods and procedures used to identify the presence of norovirus in clinical samples, environmental samples, or food samples. Norovirus is a highly contagious virus that causes acute gastroenteritis in humans. It is a common cause of outbreaks of vomiting and diarrhea, particularly in settings such as cruise ships, healthcare facilities, and restaurants.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Norovirus Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Norovirus Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Norovirus Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Norovirus Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Norovirus Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Norovirus Diagnostics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Norovirus Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, R-Biopharm, ELITechGroup, Danaher Corporation (Cepheid), Meridian Bioscience, Eiken Chemical, Altona Diagnostics, CerTest Biotec, Elisabeth Pharmacon, Qiagen, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Norovirus Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Rapid Test Kits
    PCR Kits
    ELISA Based Kits
    Market segment by Application
    Hospitals
    Diagnostics Labs
    Clinics
    Market segment by players, this report covers
    Abbott
    R-Biopharm
    ELITechGroup
    Danaher Corporation (Cepheid)
    Meridian Bioscience
    Eiken Chemical
    Altona Diagnostics
    CerTest Biotec
    Elisabeth Pharmacon
    Qiagen
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Norovirus Diagnostics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Norovirus Diagnostics, with revenue, gross margin, and global market share of Norovirus Diagnostics from 2021 to 2026.
    Chapter 3, the Norovirus Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Norovirus Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Norovirus Diagnostics.
    Chapter 13, to describe Norovirus Diagnostics research findings and conclusion.

    Buy now